Validation of FGFR screening by uromonitor and therascreen in FFPE tissue in bladder cancer in the context of the clinical-pathological real-world registry study “Bladder BRIDGister”
2024; Elsevier BV; Volume: 85; Linguagem: Inglês
10.1016/s0302-2838(24)01163-1
ISSN1873-7560
AutoresThorsten Ecke, Elke Veltrup, F. Linden, Hugo Prazeres, José Brás, Carolina Dias, Roland Hake, Sebastian Eidt, João Vinagre, Paula Soares, Stefan Koch, J. Roggisch, Dimitri Barski, A. Gössl, T. Otto, Matthias May, Anna Kravchuk, N. Gagel, Frank Friedersdorff, Lilli Sommerfeldt, Robert Stöhr, Ralph M. Wirtz,
Tópico(s)Cardiovascular Disease and Adiposity
Referência(s)